T1	Treatment 506 557	status of BRAF c.1799T>A (p.V600E) mutation and MSI
T2	Treatment 631 692	chemotherapy trial [5-fluorouracil and leucovorin (FU/LV) vs.
T3	Treatment 693 729	irinotecan (CPT11), FU and LV (IFL);
T4	Treatment 874 886	chemotherapy
T5	Treatment 1490 1493	IFL
T6	Treatment 1501 1506	FU/LV
T7	Treatment 1599 1602	IFL
T8	Treatment 1645 1650	FU/LV
T9	Treatment 1893 1918	irinotecan-based therapy.
